Pushing forward into the darkness, leaping, and landing securely: Prognostication and adjuvant chemotherapy for lung cancer

Chest

Volumn 140, Issue 6, 2011, Pages 1398-1400

  Detterbeck, Frank C ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER INVASION; CANCER MORTALITY; CANCER RECURRENCE; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; CAUSE OF DEATH; COHORT ANALYSIS; DISEASE FREE SURVIVAL; EDITORIAL; HISTOPATHOLOGY; HUMAN; LUNG NON SMALL CELL CANCER; LUNG RESECTION; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK;

EID: 83455201220     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.11-1988     Document Type: Editorial

References (6)

1. Maeda R, Yoshida J, Ishii G, Hishida T, Nishimura M, Nagai K. Risk factors for tumor recurrence in patients with early-stage (stage I and II) non-small cell lung cancer: patient selection criteria for adjuvant chemotherapy according to the seventh edition TNM classification. Chest. 2011;140(6):1494-1502.
2. Gelman R, Gelber R, Henderson IC, Coleman CN, Harris JR. Improved methodology for analyzing local and distant recurrence. J Clin Oncol. 1990;8(3):548-555.
3. Morgensztern D, Ng SH, Gao F, Govindan R. Trends in stage distribution for patients with non-small cell lung cancer: a National Cancer Database survey. J Thorac Oncol. 2010;5(1):29-33.
4. Detterbeck F, Gibson C. Turning gray: the natural history of lung cancer over time. J Thorac Oncol. 2008;3(7):781-792.
5. Groome PA, Bolejack V, Crowley J, et al. The IASLC Lung Cancer Staging project: validation of the proposals for revision of the t, n, and m descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol. 2007;2(8):694-705. (Pubitemid 47357521)
6. Boffa D, Detterbeck F, Smith E, et al. Should the 7th edition of the lung cancer stage classification system change treatment algorithms in NSCLC? J Thorac Oncol. 2010;5(11):1779-1783.